Related references
Note: Only part of the references are listed.A phase II study to evaluate lenalidomide in combination with metronomic-dose cyclophosphamide in patients with heavily pretreated classical Hodgkin lymphoma
Antonio Rueda et al.
ACTA ONCOLOGICA (2015)
Advances in the molecular functions of syndecan-1 (SDC1/CD138) in the pathogenesis of malignancies
Rajendra Gharbaran
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Shed Syndecan-1 Translocates to the Nucleus of Cells Delivering Growth Factors and Inhibiting Histone Acetylation A NOVEL MECHANISM OF TUMOR-HOST CROSS-TALK
Mark D. Stewart et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan-1 shedding
Ye Zeng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Evaluating Sphingosine and its Analogues as Potential Alternatives for Aggressive Lymphoma Treatment
Constantin Bode et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Fibrosis Marker Syndecan-1 and Outcome in Patients With Heart Failure With Reduced and Preserved Ejection Fraction
Jasper Tromp et al.
CIRCULATION-HEART FAILURE (2014)
Transcription Factor IRF4 Regulates Germinal Center Cell Formation through a B Cell-Intrinsic Mechanism
Simon N. Willis et al.
JOURNAL OF IMMUNOLOGY (2014)
Prognostic significance of immunohistochemical expression of the angiogenic molecules vascular endothelial growth factor-A, vascular endothelial growth factor receptor-1 and vascular endothelial growth factor receptor-2 in patients with classical Hodgkin lymphoma
Georgios S. Dimtsas et al.
LEUKEMIA & LYMPHOMA (2014)
Insulin-Like Growth Factor 1 Receptor Is a Prognostic Factor in Classical Hodgkin Lymphoma
Zheng Liang et al.
PLOS ONE (2014)
WT1 regulates angiogenesis in Ewing Sarcoma
Varalakshmi Katuri et al.
ONCOTARGET (2014)
Overexpression of HOXB9 promotes metastasis and indicates poor prognosis in colon cancer
Kai Huang et al.
CHINESE JOURNAL OF CANCER RESEARCH (2014)
Mapping of matrix metalloproteinase cleavage sites on syndecan-1 and syndecan-4 ectodomains
Tina Manon-Jensen et al.
FEBS JOURNAL (2013)
Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells
Christina J. Malavaki et al.
FEBS JOURNAL (2013)
Syndecan-1 modulates β-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation
Hebatallah Hassan et al.
FEBS JOURNAL (2013)
Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between αVβ3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis
Alan C. Rapraeger et al.
FEBS JOURNAL (2013)
Frequent expression of follicular dendritic cell markers in Hodgkin lymphoma and anaplastic large cell lymphoma
Soo Hee Kim et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+cells in poor outcome Hodgkin lymphoma patients
Rajendra Gharbaran et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells
Keiji Shimada et al.
JOURNAL OF PATHOLOGY (2013)
Sphingosine-1-phosphate receptor 1 in classical Hodgkin lymphoma: assessment of expression and role in cell migration
Michael J. Kluk et al.
LABORATORY INVESTIGATION (2013)
Induction of Endoplasmic Reticulum Stress by Sorafenib and Activation of NF-κB by Lestaurtinib as a Novel Resistance Mechanism in Hodgkin Lymphoma Cell Lines
Meike Stefanie Holz et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Soluble and Membrane-Bound TGF-β-Mediated Regulation of Intratumoral T Cell Differentiation and Function in B-Cell Non-Hodgkin Lymphoma
Zhi-Zhang Yang et al.
PLOS ONE (2013)
Matrix Metalloproteinase-9 Expression by Hodgkin-Reed-Sternberg Cells Is Associated with Reduced Overall Survival in Young Adult Patients with Classical Hodgkin Lymphoma
Antonio Hugo Campos et al.
PLOS ONE (2013)
Differential Surface Expression of ADAM10 and ADAM17 on Human T Lymphocytes and Tumor Cells
Henriette Ebsen et al.
PLOS ONE (2013)
Hodgkin-Reed-Sternberg Cells in Classical Hodgkin Lymphoma Show Alterations of Genes Encoding the NADPH Oxidase Complex and Impaired Reactive Oxygen Species Synthesis Capacity
Maciej Giefing et al.
PLOS ONE (2013)
Wilms' Tumor Gene 1: A Possible New Proangiogenic Factor in Hodgkin Lymphoma
Zahava Vadasz et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2013)
Exosomes in Prostate Cancer: Putting Together the Pieces of a Puzzle
Carolina Soekmadji et al.
Cancers (2013)
The role of syndecan-1 in cellular signaling and its effects on heparan sulfate biosynthesis in mesenchymal tumors
Tunde Szatmari et al.
FRONTIERS IN ONCOLOGY (2013)
HOXB9 Expression Promoting Tumor Cell Proliferation and Angiogenesis Is Associated with Clinical Outcomes in Breast Cancer Patients
Hirohito Seki et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Evaluation of BCL-6, CD10, CD 138 and MUM-1 Expression in Diffuse Large B-Cell Lymphoma patients: CD138 is a Marker of Poor Prognosis
Khaldon Bodoori et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
PI3Kδ inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma
Sarah A. Meadows et al.
BLOOD (2012)
Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection
J. Nunes et al.
BRITISH JOURNAL OF CANCER (2012)
Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin's lymphoma
Chuanhui Xu et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma
George Tsirakis et al.
HEMATOLOGICAL ONCOLOGY (2012)
Heparanase Enhances the Insulin Receptor Signaling Pathway to Activate Extracellular Signal-regulated Kinase in Multiple Myeloma
Anurag Purushothaman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells
S. Lamorte et al.
LEUKEMIA (2012)
Mast cells promote the growth of Hodgkin's lymphoma cell tumor by modifying the tumor microenvironment that can be perturbed by bortezomib
H. Mizuno et al.
LEUKEMIA (2012)
Syndecan-syntenin-ALIX regulates the biogenesis of exosomes
Maria Francesca Baietti et al.
NATURE CELL BIOLOGY (2012)
Syndecan-1 Enhances Proliferation, Migration and Metastasis of HT-1080 Cells in Cooperation with Syndecan-2
Balint Peterfia et al.
PLOS ONE (2012)
Novel Genes and Pathways Modulated by Syndecan-1: Implications for the Proliferation and Cell-Cycle Regulation of Malignant Mesothelioma Cells
Tunde Szatmari et al.
PLOS ONE (2012)
Syndecan-2 cytoplasmic domain regulates colon cancer cell migration via interaction with syntenin-1
Hawon Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma
Todd A. Fehniger et al.
BLOOD (2011)
Classical Hodgkin's lymphoma shows epigenetic features of abortive plasma cell differentiation
Volkhard Seitz et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Heparanase Plays a Dual Role in Driving Hepatocyte Growth Factor (HGF) Signaling by Enhancing HGF Expression and Activity
Vishnu C. Ramani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
WT1 Protein Directly Regulates Expression of Vascular Endothelial Growth Factor and Is a Mediator of Tumor Response to Hypoxia
Gregory McCarty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment
Christian Steidl et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3
Thiha Aung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis
Anurag Purushothaman et al.
BLOOD (2010)
Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma
Boris Boell et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma
R. Garcia-Sanz et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
A Disintegrin and Metalloproteinase 17 (ADAM17) Mediates Inflammation-induced Shedding of Syndecan-1 and-4 by Lung Epithelial Cells
Jessica Pruessmeyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation
DeannaLee M. Beauvais et al.
JOURNAL OF CELL SCIENCE (2010)
Anemia in Hodgkin's Lymphoma: The Role of Interleukin-6 and Hepcidin
Stefan Hohaus et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Proteomics Analysis of Bladder Cancer Exosomes
Joanne L. Welton et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
3D Telomere FISH defines LMP1-expressing Reed-Sternberg cells as end-stage cells with telomere-poor 'ghost' nuclei and very short telomeres
Hans Knecht et al.
LABORATORY INVESTIGATION (2010)
The Role of Cytotoxic and Regulatory T cells in Relapsed/Refractory Hodgkin Lymphoma
Aashiyana F. Koreishi et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2010)
TGF-β and fibrosis in different organs - molecular pathway imprints
Dirk Pohlers et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression
Viktoriya Nikolova et al.
CARCINOGENESIS (2009)
Oxidative Stress Alters Syndecan-1 Distribution in Lungs with Pulmonary Fibrosis
Corrine R. Kliment et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Syndecan-2 Regulates the Migratory Potential of Melanoma Cells
Jung-Hyun Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Syndecan-1 regulates αvβ3 and αvβ5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor
DeannaLee M. Beauvais et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Effects of the Anti-VEGF Monoclonal Antibody Bevacizumab in a Preclinical Model and in Patients With Refractory and Multiple Relapsed Hodgkin Lymphoma
Katrin S. Reiners et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Heparanase Regulates Levels of Syndecan-1 in the Nucleus
Ligong Chen et al.
PLOS ONE (2009)
Histological expression of angiogenic factors: VEGF, PDGFR alpha, and HIF-1 alpha in Hodgkin lymphoma
Freda H. Passam et al.
PATHOLOGY RESEARCH AND PRACTICE (2009)
PLASMA HEPARANASE AS A SIGNIFICANT MARKER OF TREATMENT RESPONSE IN CHILDREN WITH HODGKIN LYMPHOMA: Pilot Study
Myriam Weyl Ben Arush et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2009)
Syndecan-4 regulates platelet-derived growth factor-mediated MAP kinase activation by altering intracellular reactive oxygen species
Jungyean Kim et al.
FEBS LETTERS (2008)
Syndecan-1 Ectodomain Shedding Is Regulated by the Small GTPase Rab5
Kazutaka Hayashida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Heparanase Stimulation of Protease Expression Implicates It as a Master Regulator of the Aggressive Tumor Phenotype in Myeloma
Anurag Purushothaman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype
A. Ehlers et al.
LEUKEMIA (2008)
The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression
Todd W. Kelley et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Proteomic analysis of microvesicles derived from human colorectal cancer cells
Dong-Sic Choi et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Epstein-Barr virus latent membrane protein 1 promotes concentration in multivesicular bodies of fibroblast growth factor 2 and its release through exosomes
Simona Ceccarelli et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma:: A study from the Groupe d'Etude des Lymphomes de l'Adulte
Rene-Olivier Casasnovas et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1
Stefan Nagel et al.
BLOOD (2007)
Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma
M. O. Chandesris et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL
April Chiu et al.
BLOOD (2007)
VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues
Monia Bardelli et al.
LEUKEMIA & LYMPHOMA (2007)
Syndecans in wound healing, inflammation and vascular biology
Annika N. Alexopoulou et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: A clinicopathologic study
Naoko Asano et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Syndecan-1 expression in epithelial cells is induced by transforming growth factor β through a PKA-dependent pathway
Kazutaka Hayashida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
FGF2 binding, signaling, and angiogenesis are modulated by heparanase in metastatic melanoma cells
Jane Reiland et al.
NEOPLASIA (2006)
Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination
Ulf Klein et al.
NATURE IMMUNOLOGY (2006)
B-cell differentiation immunophenotypes in classical Hodgkin lymphomas
M Bai et al.
LEUKEMIA & LYMPHOMA (2006)
An APRIL to remember: novel TNF ligands as therapeutic targets
SR Dillon et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PdEGF) in classical Hodgkin lymphoma (HL)
T Mainou-Fowler et al.
LEUKEMIA & LYMPHOMA (2006)
A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma
J Kuruvilla et al.
HEMATOLOGY (2006)
The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma
D Khnykin et al.
JOURNAL OF PATHOLOGY (2006)
Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma
EPM Tjin et al.
BLOOD (2006)
Transmembrane domain-induced oligomerization is crucial for the functions of syndecan-2 and syndecan-4
S Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma
M Buettner et al.
HEMATOLOGICAL ONCOLOGY (2005)
Immunohistochemistry accurately predicts FGFR3 aberrant expression and t(4;14) in multiple myeloma
H Chang et al.
BLOOD (2005)
Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications
P Korkolopoulou et al.
LEUKEMIA (2005)
Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation
J Hendriks et al.
CELL DEATH AND DIFFERENTIATION (2005)
Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymohoma
C Renné et al.
BLOOD (2005)
Identification of proteoglycans as the APRIL-specific binding partners
K Ingold et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Syndecans - New kids on the signaling block
E Tkachenko et al.
CIRCULATION RESEARCH (2005)
Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells
T Alvaro et al.
CLINICAL CANCER RESEARCH (2005)
The plateled-derived growth factor level (PDGF) in Hodgkin's disease and non-Hodgkin's lymphoma and its relationship disease activation
N Güler et al.
HEMATOLOGY (2005)
RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44
N Charnaux et al.
GLYCOBIOLOGY (2005)
Therapeutic renaissance of thalidomide in the treatment of haematological malignancies
D Ribatti et al.
LEUKEMIA (2005)
Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival
NF Andersen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
TGF-β signaling and the fibrotic response
A Leask et al.
FASEB JOURNAL (2004)
Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease
MC Kyrtsonis et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2004)
Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma
NA Marshall et al.
BLOOD (2004)
Syndecan-1 expression in locally invasive and metastatic prostate cancer
D Chen et al.
UROLOGY (2004)
Activation of syndecan-1 ectodomain shedding by Staphylococcus aureus α-toxin and β-toxin
PW Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Syndecan-1 up-regulated by ephrinB2/EphB4 plays dual roles in inflammatory angiogenesis
K Yuan et al.
BLOOD (2004)
The syndecan-1 ectodomain regulates αvβ3 integrin activity in human mammary carcinoma cells
DLM Beauvais et al.
JOURNAL OF CELL BIOLOGY (2004)
Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration
K Endo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Plasminogen activator inhibitor-1 supports IL-8-mediated neutrophil transendothelial migration by inhibition of the constitutive shedding of endothelial IL-8/heparan sulfate/syndecan-1 complexes
LJ Marshall et al.
JOURNAL OF IMMUNOLOGY (2003)
MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival
B Zheng et al.
BLOOD (2003)
Syndecan-1-mediated cell spreading requires signaling by αvβ3 integrins in human breast carcinoma cells
DM Beauvais et al.
EXPERIMENTAL CELL RESEARCH (2003)
A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?
KSM Smalley
INTERNATIONAL JOURNAL OF CANCER (2003)
Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling
E Hsia et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma
PWB Derksen et al.
LEUKEMIA (2003)
Regulation of epithelial syndecan-1 expression by inflammatory cytokines
RM Day et al.
CYTOKINE (2003)
Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2
S Joos et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Expression of B-cell markers in classical Hodgkin lymphoma: A tissue microarray analysis of 330 cases
A Tzankov et al.
MODERN PATHOLOGY (2003)
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma
R Zanotti et al.
ANNALS OF ONCOLOGY (2002)
Hepatocyte growth factor in myeloma patients treated with high-dose chemotherapy
C Seidel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury
QL Li et al.
CELL (2002)
Cytokine regulation of syndecan-1 and-2 gene expression in human periodontal fibroblasts and osteoblasts
W Worapamorn et al.
JOURNAL OF PERIODONTAL RESEARCH (2002)
Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease
IA Doussis-Anagnostopoulou et al.
JOURNAL OF PATHOLOGY (2002)
Interleukin 6 expression by Hodgkin/Reed-Sternberg cells is associated with the presence of 'B' symptoms and failure to achieve complete remission in patients with advanced Hodgkin's disease
GM Reynolds et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Transforming growth factor-β1-induced collagen production in cultures of cardiac fibroblasts is the result of the appearance of myofibroblasts
P Lijnen et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2002)
The role of cytokines in classical Hodgkin lymphoma
BF Skinnider et al.
BLOOD (2002)
Elevated level of plasma basic fibroblast growth factor in multiple myeloma correlates with increased disease activity
N Sato et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2002)
Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma
PWB Derksen et al.
BLOOD (2002)
Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8:: A model for chemokine regulation at inflammatory sites
B Goger et al.
BIOCHEMISTRY (2002)
LMP1-induced downregulation of CD99 molecules in Hodgkin and Reed-Sternberg cells
IS Lee et al.
LEUKEMIA & LYMPHOMA (2001)
A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-γ and DNA synthesis in vascular endothelial cells
T Takahashi et al.
EMBO JOURNAL (2001)
Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease
L Teofili et al.
BLOOD (2001)
Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2) - A reassessment using novel receptor-specific vascular endothelial growth factor mutants
H Gille et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis
MA Frassanito et al.
BLOOD (2001)
Protein tyrosine kinases in malignant melanoma
DJ Easty et al.
MELANOMA RESEARCH (2000)
Differentiation of mesothelioma cells is influenced by the expression of proteoglycans
K Dobra et al.
EXPERIMENTAL CELL RESEARCH (2000)
Cell growth and matrix invasion of EBV-immortalized human B lymphocytes is regulated by expression of αv integrins
S Huang et al.
ONCOGENE (2000)
Shedding of syndecan-1 and-4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase
ML Fitzgerald et al.
JOURNAL OF CELL BIOLOGY (2000)
Share Paper
